Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2023-11-20 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯2023年第三次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2023 Third Extraordinary General Meeting of Shareholders" of 普莱柯生物工程股份有限公司. It contains detailed meeting instructions, agenda, voting procedures, and two specific proposals for shareholder approval: (1) cancellation of repurchased shares, and (2) reduction of registered capital and amendment of the company charter. The document is procedural and informational for the shareholders to prepare for and participate in the meeting. It does not contain financial statements, audit opinions, or earnings data. It is not a report but rather meeting materials for a shareholder meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is about 4000 characters, consistent with meeting materials rather than a full report. Therefore, the correct classification is AGM Information (AGM-R).
2023-11-20 Chinese
普莱柯关于以集中竞价交易方式回购公司股份的回购报告书
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from a company about its plan to repurchase shares through centralized bidding on the stock exchange. It includes specifics such as the purpose of the repurchase (for equity incentives and employee stock ownership plans), the amount of funds allocated, the repurchase period, price limits, funding sources, and the impact on the company's financials and shareholding structure. It also discusses the authorization of management to execute the repurchase and the risks involved. This type of document is a formal report on the company's share buyback plan and progress, which fits the category of a Transaction in Own Shares (POS) report. It is not a simple announcement of a report publication, nor is it an earnings release or capital change announcement. The length and detail confirm it is the report itself, not just a notice or summary.
2023-11-20 Chinese
普莱柯关于前十大股东持股情况的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement from 普莱柯生物工程股份有限公司 regarding the shareholding situation of the top 10 shareholders as of November 13, 2023. It includes detailed tables of shareholdings and percentages, and references a board resolution about share repurchase. The document is primarily focused on notifying the market about the current major shareholders and their holdings, which fits the definition of a Major Shareholding Notification. The document length is short (1703 characters), and it is not a full financial report or earnings release. It is not a report publication announcement or regulatory filing as it contains substantive data on shareholdings. Therefore, the best classification is Major Shareholding Notification (MRQ).
2023-11-16 Chinese
普莱柯第五届董事会第七次会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司, including approval of a share repurchase plan, authorization of management to execute the repurchase, and plans for capital reduction and amendments to the company charter. It includes voting results and procedural details but does not contain financial statements or quarterly/yearly financial results. The content focuses on board decisions regarding share repurchase and capital changes, which aligns with announcements about share buybacks or capital structure changes. The document length is 3524 characters, which is relatively short but contains substantive details about the share repurchase plan rather than just a brief notice. Therefore, it is best classified as a Transaction in Own Shares (POS) filing, which covers company announcements about share repurchases or sales of own shares.
2023-11-13 Chinese
普莱柯关于注销已回购股份的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company regarding the cancellation of repurchased shares. It details the background of the share repurchase, the number of shares to be cancelled, the impact on share capital structure, and confirms that the cancellation will not affect the company's listing status or financial condition. There are no financial statements or detailed financial performance data included. The document is a formal announcement about a capital change event (cancellation of treasury shares). This fits the category of Share Issue/Capital Change (SHA). The document length is short and focused on this specific corporate action, not a full report or regulatory filing.
2023-11-13 Chinese
普莱柯关于召开2023年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2023 third extraordinary general meeting of shareholders, including meeting date, voting methods, agenda items, registration details, and proxy authorization. It does not contain financial statements or results but is an announcement related to a shareholder meeting. It is not a report itself but a meeting notice. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is under 5,000 characters and is a meeting notice rather than a report or voting results announcement.
2023-11-13 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.